KRAS and rectal neoplasm: Primary rectal tumor tended to be more frequently observed in KRAS exon 2 and other RAS mutant tumors than in RAS wild-type tumors (60.0 vs. 61.9 vs. 48.3%, P = 0.08) (Table 1), although this was not statistically significant.